Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 82 of the 84 references it cites were found in a registry or an index.

Type 2 Diabetes as a Risk Factor for Alzheimer's Disease: The Confounders, Interactions, and Neuropathology Associated With This Relationship

Vagelatos, N. T., Eslick, G. D. · 2013 · Epidemiologic Reviews

Abstract

We performed a systematic review and meta-analysis to explore whether type 2 diabetes mellitus (T2DM) increases the risk of Alzheimer's disease (AD). We also reviewed interactions with smoking, hypertension, and apolipoprotein E ɛ4. Using a series of databases (MEDLINE, EMBASE, PubMed, Current Contents Connect, and Google Scholar), we identified a total of 15 epidemiologic studies. Fourteen studies reported positive associations, of which 9 were statistically significant. Risk estimates ranged from 0.83 to 2.45. The pooled adjusted risk ratio was 1.57 (95% confidence interval: 1.41, 1.75), with a population-attributable risk of 8%. Smoking and hypertension, when comorbid with T2DM, had odds of 14 and 3, respectively. Of the 5 studies that investigated the interaction between T2DM and apolipoprotein E ɛ4, 4 showed positive associations, of which 3 were significant, with odds ranging from 2.4 to 4.99. The pooled adjusted risk ratio was 2.91 (95% confidence interval: 1.51, 5.61). Risk estimates were presented in the context of a key confounder-cerebral infarcts-which are more common in those with T2DM and might contribute to the manifestation of clinical AD. We provide evidence from clinico-neuropathologic studies that demonstrates the following: First, cerebral infarcts are more common than AD-type pathology in those with T2DM and dementia. Second, those with dementia at postmortem are more likely to have both AD-type and cerebrovascular pathologies. Finally, cerebral infarcts reduce the number of AD lesions required for the manifestation of clinical dementia, but they do not appear to interact synergistically with AD-type pathology. Therefore, the increased risk of clinically diagnosed AD seems to be mediated through cerebrovascular pathology.

Overview

Integrity signals

Registry

Crossref · 10.1093/epirev/mxs012

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 84 references

Research works printed but not linked: 3

  1. 1994, Journal of Clinical Endocrinology & Metabolism, 78, 809A, 10.1210/jc.78.4.809a · doi:10.1210/jc.78.4.809a
  2. 1983, J EDUC STAT, 8, 157
  3. 2010, EGYPT J NEUROL PSYCHIAT NEUROSURG, 47, 419

Cited by

See all 320

Metadata

Authors
Vagelatos, N. T., & Eslick, G. D.
Affiliations
The University of Sydney (AU)
Corresponding author
Eslick, G. D.
Venue
Epidemiologic Reviews
Published
2013-01-01
Volume
35
Issue
1
Pages
152-160
ISSN
  • 0193-936X (ISSN-L)
  • 1478-6729
OpenAlex
W2152272404
Cited by
320
References
84
Citations by year
2026: 10 · 2025: 21 · 2024: 26 · 2023: 16 · 2022: 26 · 2021: 32 · 2020: 28 · 2019: 25 · 2018: 29 · 2017: 23 · 2016: 25 · 2015: 23 · 2014: 19 · 2013: 16
FWCI
3.77
Type
journal article
Language
en
Open access
closed
Locations
  • Epidemiologic Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
Sydney Medical School
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, Alzheimer's disease, dementia risk, cerebral infarction, cerebrovascular pathology, APOE ε4, smoking, hypertension, confounding, neuropathology
MeSH terms
Alzheimer Disease, Brain, Cerebral Infarction, Diabetes Mellitus, Type 2, Humans, Hypertension, Regression Analysis, Risk Factors, Smoking, Confounding Factors, Epidemiologic, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Type 2 Diabetes as a Risk Factor for Alzheimer's Disease: The Confounders, Interactions, and Neuropathology Associated With This Relationship. https://app.cochat.ai/papers/10.1093/epirev/mxs012
The paper
Vagelatos, N. T., & Eslick, G. D. (2013). Type 2 Diabetes as a Risk Factor for Alzheimer's Disease: The Confounders, Interactions, and Neuropathology Associated With This Relationship. Epidemiologic Reviews. https://doi.org/10.1093/epirev/mxs012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.